Thank you to our sponsors!

Alcom
Durysta
Ellex
Horizon
Harvest
Ivantis
Mallinckrodt
Ocular
Omeros
Regeneron

Find an Eye MD near you!

Allergan announced it will develop and commercialize dry eye drug tavilermide through an exclusive licensing agreement with Mimetogen Pharmaceuticals.

Researchers have identified a steroid that has the potential to reverse cataracts by blocking α-crystallin aggregation.

Study finds that glaucoma patients are at higher risk for complications and show weaker visual improvement.

AGTC has filed a new drug application with the FDA to conduct a clinical trial of a gene therapy product to treat achromatopsia.

Case report brings to light a potentially under-diagnosed cause of ocular neuropathic pain – vitamin B12 deficiency.

Literature review finds no evidence to support routine use of NSAIDs after cataract surgery to prevent vision loss from CME.

Twitter

Diagnose This: Minimizing ocular movement during phacoemulsification

◦Attention colleagues! Please reach out to your member of Congress regarding the rising drug prices and lack of tra… https://t.co/XKu7NezQAj

Looks like a great weekend for the WVAEPS 2018 Scientific Conference at the Greenbrier!!! Hope you made your regis… https://t.co/CNa5LLXj1t

Suffering eye strain at work? Follow these tips from the American Academy of Ophthalmology to get some relief. https://t.co/tfR8etzzG9